Neuromodulation

Neuromodulation alters nerve activity by delivering electrical or pharmaceutical agents directly to a target area. This feed focuses on different types of light therapies and methods, including optogenetics and low-level laser applications.

January 21, 2022
Preprint
Open Access

Basal amygdala inputs to the medial prefrontal cortex mediate fear memory strengthening

BioRxiv : the Preprint Server for Biology
E. EinarssonCyril Herry
January 21, 2022
Review
Open Access

Red Light Optogenetics in Neuroscience.

Frontiers in Cellular Neuroscience
Kimmo LehtinenHeikki Takala
January 21, 2022
Review
Open Access

Neurophysiology of the Developing Cerebral Cortex: What We Have Learned and What We Need to Know.

Frontiers in Cellular Neuroscience
Heiko J Luhmann
January 21, 2022
Review

Evolution of the Vagus Nerve Stimulation (VNS) Therapy System Technology for Drug-Resistant Epilepsy.

Frontiers in Medical Technology
Pegah AfraGlenn David Robert Watson
January 21, 2022

Technological Improvement Rates and Evolution of Energy-Based Therapeutics.

Frontiers in Medical Technology
Subarna Basnet, Christopher L Magee
January 21, 2022

In Vivo Organic Bioelectronics for Neuromodulation.

Chemical Reviews
Magnus BerggrenKlas Tybrandt
January 21, 2022

Large-scale EEG neural network changes in response to therapeutic TMS.

Brain Stimulation
Michael C GoldLinda L Carpenter
January 21, 2022

Serotype-based evaluation of an optogenetic construct in rat cortical astrocytes.

Biochemical and Biophysical Research Communications
Lakshmini BalachandarJorge Riera Diaz
January 20, 2022
Preprint
Open Access

pyNeurode: a real-time neural signal processing framework

BioRxiv : the Preprint Server for Biology
W. K. Tam, Matthew F Nolan
January 20, 2022
Preprint
Open Access

Region Selective Cortical Control Of The Thalamic Reticular Nucleus

BioRxiv : the Preprint Server for Biology
N. HadingerLaszlo Acsady
January 20, 2022

Dopamine release in nucleus accumbens is under tonic inhibition by adenosine A1 receptors regulated by astrocytic ENT1 and dysregulated by ethanol.

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
Bradley M RobertsStephanie J Cragg
January 20, 2022

Dual PI3Kδ/γ Inhibitor Duvelisib Prevents Development of Neuropathic Pain in Model of Paclitaxel-Induced Peripheral Neuropathy.

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
Pavel AdamekJiri Palecek
January 20, 2022

Dissection of brain-wide resting-state and functional somatosensory circuits by fMRI with optogenetic silencing.

Proceedings of the National Academy of Sciences of the United States of America
Won Beom JungSeong-Gi Kim
January 20, 2022

Role of melatonin in autism spectrum disorders in a male murine transgenic model: Study in the prefrontal cortex.

Journal of Neuroscience Research
Elisa BorsaniRita Rezzani

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2022 Meta ULC. All rights reserved
/feed-previews/photobiomodulation-neuromodulation/60cb612a-fc8e-4df3-b03f-67ed5d403749